Literature DB >> 12387309

Toxicity of methylsulfonylmethane in rats.

K Horváth1, P E Noker, S Somfai-Relle, R Glávits, I Financsek, A G Schauss.   

Abstract

Methylsulfonylmethane (MSM) is a popular dietary supplement used in a variety of conditions including pain, inflammation, allergies, arthritis, parasitic infections and the maintenance of normal keratin levels in hair, skin and nails. Despite its popularity, there is little published toxicology data on MSM. The objective of this study was to evaluate the acute and subchronic toxicity of MSM in rats at a dose five to seven times the maximum recommended dose in humans. MSM administered in a single gavage dose of 2 g/kg resulted in no adverse events or mortality. MSM administered as a daily dose of 1.5 g/kg for 90 days by gavage resulted in no adverse events or mortality. Necropsy did not reveal any gross pathological lesions or changes in organ weights. Renal histology of treated animals was normal. It is concluded that MSM is well tolerated in rats at an acute dose of 2 g/kg and at a subacute chronic dose of 1.5 g/kg.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387309     DOI: 10.1016/s0278-6915(02)00086-8

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  18 in total

1.  Multiorgan dysfunction syndrome secondary to joint supplement overdosage in a dog.

Authors:  Irma J Nobles; Safdar Khan
Journal:  Can Vet J       Date:  2015-04       Impact factor: 1.008

2.  Cytotoxicity of methylsulfonylmethane on gastrointestinal (AGS, HepG2, and KEYSE-30) cancer cell lines.

Authors:  Naser Jafari; Shahab Bohlooli; Sadollah Mohammadi; Mohammad Mazani
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model.

Authors:  Junko Ezaki; Miyuki Hashimoto; Yu Hosokawa; Yoshiko Ishimi
Journal:  J Bone Miner Metab       Date:  2012-08-10       Impact factor: 2.626

4.  Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review.

Authors:  Kent Stuber; Sandy Sajko; Kevyn Kristmanson
Journal:  J Can Chiropr Assoc       Date:  2011-03

5.  Methylsulfonylmethane suppresses hepatic tumor development through activation of apoptosis.

Authors:  Joo-Hyun Kim; Hye-Jun Shin; Hye-Lin Ha; Young-Ho Park; Tae-Ho Kwon; Mi-Ra Jung; Hyung-Bae Moon; Eun-Sang Cho; Hwa-Young Son; Dae-Yeul Yu
Journal:  World J Hepatol       Date:  2014-02-27

6.  Methyl sulfone induces loss of metastatic properties and reemergence of normal phenotypes in a metastatic cloudman S-91 (M3) murine melanoma cell line.

Authors:  Joan McIntyre Caron; Marissa Bannon; Lindsay Rosshirt; Jessica Luis; Luke Monteagudo; John M Caron; Gerson Marc Sternstein
Journal:  PLoS One       Date:  2010-08-04       Impact factor: 3.240

7.  Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways.

Authors:  Eun Joung Lim; Dae Young Hong; Jin Hee Park; Youn Hee Joung; Pramod Darvin; Sang Yoon Kim; Yoon Mi Na; Tae Sook Hwang; Sang-Kyu Ye; Eon-Soo Moon; Byung Wook Cho; Kyung Do Park; Hak Kyo Lee; Taekyu Park; Young Mok Yang
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

8.  The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts.

Authors:  Nipin S P; Pramod Darvin; Young Beom Yoo; Youn Hee Joung; Dong Young Kang; Don Nam Kim; Tae Sook Hwang; Sang Yoon Kim; Wan Seop Kim; Hak Kyo Lee; Byung Wook Cho; Heui Soo Kim; Kyung Do Park; Jong Hwan Park; Soung Hoon Chang; Young Mok Yang
Journal:  BMC Cancer       Date:  2015-06-19       Impact factor: 4.430

9.  MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs.

Authors:  Youn Hee Joung; Eun Joung Lim; Pramod Darvin; So Chung Chung; Ju Woong Jang; Kyung Do Park; Hak Kyo Lee; Heui Soo Kim; Taekyu Park; Young Mok Yang
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

10.  Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee.

Authors:  Sarah Brien; Phil Prescott; George Lewith
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.